Drugs in the Pipeline
Efzofitimod is a potential first-in-class selective modulator of neuropilin-2 that is designed to downregulate innate and adaptive immune responses in inflammatory disease states.
News
Dupixent single-dose prefilled pens feature a hidden needle and single-press auto-injection.
News
The approval was based on data from two phase 3 induction studies and one phase 3 maintenance study.
Drugs in the Pipeline
Vamorolone is a first-in-class dissociative steroidal drug that retains the anti-inflammatory activity of corticosteroids but with a novel mechanism of action.
